scholarly journals Lack of association between Epstein–Barr virus and mammary tumours in dogs

2018 ◽  
Vol 62 (3) ◽  
pp. 309-315
Author(s):  
Gustavo A. Roa López ◽  
Jhon Jairo Suárez ◽  
Paola Barato ◽  
Noel Verján García

AbstractIntroductionEpstein–Barr virus (EBV) is a γ-herpesvirus associated with various neoplasms in humans and is a probable aetiological agent in breast cancer; however, a causal relationship has not yet been established. Because of the epidemiological and clinicopathological similarities between breast cancer and canine mammary tumours, dogs have been proposed as a valid model for breast cancer.Material and MethodsA total of 47 canine mammary gland tumour tissues were processed by routine histopathological technique with haematoxylin-eosin staining and classified according to the type of neoplasm. DNA was extracted from paraffin-embedded tissues and the EBNA-1 gene and the BamHI-W region specific for EBV were evaluated by nested PCR.ResultsThe histopathological evaluation revealed 2 benign neoplasms, and many carcinomas: 2 in situ, 9 simple, 3 solid, 10 complex, and 21 mixed. One sample was positive for the EBNA-1 gene, while all were negative for the BamHI-W region.ConclusionNo association was found between EBV and mammary tumours in dogs. However, here we report for the first time the presence of an EBV gene sequence in a canine mammary tumour. It is likely that detection of EBV might be affected by the quality and quantity of DNA extracted from paraffin-embedded tissues. Additional studies are necessary to establish any association of EBV with mammary gland cancer in humans and in dogs, which could eventually lead to better public health prevention and control.

2017 ◽  
Vol 24 (1) ◽  
pp. 16-22 ◽  
Author(s):  
Trupti Pai ◽  
Sudeep Gupta ◽  
Mamta Gurav ◽  
Shona Nag ◽  
Tanuja Shet ◽  
...  

1998 ◽  
Vol 124 (1) ◽  
pp. 53-57 ◽  
Author(s):  
Jan-Show Chu ◽  
Chung-Chung Chen ◽  
King-Jen Chang

2011 ◽  
Vol 132 (1) ◽  
pp. 267-274 ◽  
Author(s):  
Kimberly Baltzell ◽  
Gertrude C. Buehring ◽  
Savitri Krishnamurthy ◽  
Henry Kuerer ◽  
Hua Min Shen ◽  
...  

2011 ◽  
Vol 309 (2) ◽  
pp. 128-136 ◽  
Author(s):  
Jian-Rong He ◽  
Lu-Ying Tang ◽  
Dan-Dan Yu ◽  
Feng-Xi Su ◽  
Er-Wei Song ◽  
...  

2012 ◽  
Vol 43 (1) ◽  
pp. 393-404 ◽  
Author(s):  
Marcos Antonio Pereira de Lima ◽  
Márcia Valéria Pitombeira Ferreira ◽  
Marcos Aurélio Pessoa Barros ◽  
Maria Inês de Moura Campos Pardini ◽  
Adriana Camargo Ferrasi ◽  
...  

Blood ◽  
2007 ◽  
Vol 110 (3) ◽  
pp. 972-978 ◽  
Author(s):  
Sarah Park ◽  
Jeeyun Lee ◽  
Young Hyeh Ko ◽  
Arum Han ◽  
Hyun Jung Jun ◽  
...  

AbstractTo define prognostic impact of Epstein-Barr virus (EBV) infection in diffuse large B-cell lymphoma (DLBCL), we investigated EBV status in patients with DLBCL. In all, 380 slides from paraffin-embedded tissue were available for analysis by EBV-encoded RNA-1 (EBER) in situ hybridization, and 34 cases (9.0%) were identified as EBER-positive. EBER positivity was significantly associated with age greater than 60 years (P = .005), more advanced stage (P < .001), more than one extranodal involvement (P = .009), higher International Prognostic Index (IPI) risk group (P = .015), presence of B symptom (P = .004), and poorer outcome to initial treatment (P = .006). The EBER+ patients with DLBCL demonstrated substantially poorer overall survival (EBER+ vs EBER− 35.8 months [95% confidence interval (CI), 0-114.1 months] vs not reached, P = .026) and progression-free survival (EBER+ vs EBER− 12.8 months [95% CI, 0-31.8 months] vs 35.8 months [95% CI, 0-114.1 months], respectively (P = .018). In nongerminal center B-cell–like subtype, EBER in situ hybridization positivity retained its statistical significance at the multivariate level (P = .045). Nongerminal center B-cell–like patients with DLBCL with EBER positivity showed substantially poorer overall survival with 2.9-fold (95% CI, 1.1-8.1) risk for death. Taken together, DLBCL patients with EBER in situ hybridization+ pursued more rapidly deteriorating clinical course with poorer treatment response, survival, and progression-free survival.


2012 ◽  
Vol 24 (3) ◽  
pp. 123-131 ◽  
Author(s):  
Abdel-Rahman N. Zekri ◽  
Abeer A. Bahnassy ◽  
Waleed S. Mohamed ◽  
Fatma A. El-Kassem ◽  
Saja J. El-Khalidi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document